IBDEI0GI ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7343,1,2,0)
 ;;=2^J0713
 ;;^UTILITY(U,$J,358.3,7343,1,3,0)
 ;;=3^CEFTAZIDIME INJ PER 500 MG
 ;;^UTILITY(U,$J,358.3,7344,0)
 ;;=J0735^^51^489^10^^^^1
 ;;^UTILITY(U,$J,358.3,7344,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7344,1,2,0)
 ;;=2^J0735
 ;;^UTILITY(U,$J,358.3,7344,1,3,0)
 ;;=3^CLONIDINE HCL INJ PER 1 MG
 ;;^UTILITY(U,$J,358.3,7345,0)
 ;;=J1200^^51^489^15^^^^1
 ;;^UTILITY(U,$J,358.3,7345,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7345,1,2,0)
 ;;=2^J1200
 ;;^UTILITY(U,$J,358.3,7345,1,3,0)
 ;;=3^DIPHENHYDRAMINE HCL PER 50 MG
 ;;^UTILITY(U,$J,358.3,7346,0)
 ;;=J1270^^51^489^16^^^^1
 ;;^UTILITY(U,$J,358.3,7346,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7346,1,2,0)
 ;;=2^J1270
 ;;^UTILITY(U,$J,358.3,7346,1,3,0)
 ;;=3^DOXERCALCIFEROL INJ PER 1 MCG
 ;;^UTILITY(U,$J,358.3,7347,0)
 ;;=J1580^^51^489^21^^^^1
 ;;^UTILITY(U,$J,358.3,7347,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7347,1,2,0)
 ;;=2^J1580
 ;;^UTILITY(U,$J,358.3,7347,1,3,0)
 ;;=3^GARAMYCIN GENTAMICIN PER 80 MG
 ;;^UTILITY(U,$J,358.3,7348,0)
 ;;=J1642^^51^489^23^^^^1
 ;;^UTILITY(U,$J,358.3,7348,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7348,1,2,0)
 ;;=2^J1642
 ;;^UTILITY(U,$J,358.3,7348,1,3,0)
 ;;=3^HEPARIN SODIUM INJ PER 10 U (FLUSH)
 ;;^UTILITY(U,$J,358.3,7349,0)
 ;;=J1644^^51^489^24^^^^1
 ;;^UTILITY(U,$J,358.3,7349,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7349,1,2,0)
 ;;=2^J1644
 ;;^UTILITY(U,$J,358.3,7349,1,3,0)
 ;;=3^HEPARIN SODIUM INJ PER 1000 U
 ;;^UTILITY(U,$J,358.3,7350,0)
 ;;=J2060^^51^489^30^^^^1
 ;;^UTILITY(U,$J,358.3,7350,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7350,1,2,0)
 ;;=2^J2060
 ;;^UTILITY(U,$J,358.3,7350,1,3,0)
 ;;=3^LORAZEPAM INJ PER 2 MG
 ;;^UTILITY(U,$J,358.3,7351,0)
 ;;=J2405^^51^489^33^^^^1
 ;;^UTILITY(U,$J,358.3,7351,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7351,1,2,0)
 ;;=2^J2405
 ;;^UTILITY(U,$J,358.3,7351,1,3,0)
 ;;=3^ONDANSETRON HCL INJ PER 1 MG
 ;;^UTILITY(U,$J,358.3,7352,0)
 ;;=J2997^^51^489^3^^^^1
 ;;^UTILITY(U,$J,358.3,7352,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7352,1,2,0)
 ;;=2^J2997
 ;;^UTILITY(U,$J,358.3,7352,1,3,0)
 ;;=3^ALTEPLASE RECOMBINANT PER 1 MG
 ;;^UTILITY(U,$J,358.3,7353,0)
 ;;=J3260^^51^489^41^^^^1
 ;;^UTILITY(U,$J,358.3,7353,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7353,1,2,0)
 ;;=2^J3260
 ;;^UTILITY(U,$J,358.3,7353,1,3,0)
 ;;=3^TOBRAMYCIN SULFATE PER 80 MG
 ;;^UTILITY(U,$J,358.3,7354,0)
 ;;=J7682^^51^489^40^^^^1
 ;;^UTILITY(U,$J,358.3,7354,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7354,1,2,0)
 ;;=2^J7682
 ;;^UTILITY(U,$J,358.3,7354,1,3,0)
 ;;=3^TOBRAMYCIN NON-COM UNIT 300 MG
 ;;^UTILITY(U,$J,358.3,7355,0)
 ;;=P9047^^51^489^2^^^^1
 ;;^UTILITY(U,$J,358.3,7355,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7355,1,2,0)
 ;;=2^P9047
 ;;^UTILITY(U,$J,358.3,7355,1,3,0)
 ;;=3^ALBUMIN (HUMAN), 25%, 50ML
 ;;^UTILITY(U,$J,358.3,7356,0)
 ;;=J0886^^51^489^18^^^^1
 ;;^UTILITY(U,$J,358.3,7356,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7356,1,2,0)
 ;;=2^J0886
 ;;^UTILITY(U,$J,358.3,7356,1,3,0)
 ;;=3^EPOETIN ALFA 1000 UNITS ESRD
 ;;^UTILITY(U,$J,358.3,7357,0)
 ;;=J3370^^51^489^43^^^^1
 ;;^UTILITY(U,$J,358.3,7357,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7357,1,2,0)
 ;;=2^J3370
 ;;^UTILITY(U,$J,358.3,7357,1,3,0)
 ;;=3^VANCOMYCIN HCL 500 MG
 ;;^UTILITY(U,$J,358.3,7358,0)
 ;;=J0636^^51^489^5^^^^1
 ;;^UTILITY(U,$J,358.3,7358,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7358,1,2,0)
 ;;=2^J0636
 ;;^UTILITY(U,$J,358.3,7358,1,3,0)
 ;;=3^CALCITRIOL INJ PER 0.1 MCG
 ;;^UTILITY(U,$J,358.3,7359,0)
 ;;=J0882^^51^489^11^^^^1
 ;;^UTILITY(U,$J,358.3,7359,1,0)
 ;;=^358.31IA^3^2
